Home
Conditions
Congenital Abnormalities

Clinical trial condition

Congenital Abnormalities

Explore clinical trials studying Congenital Abnormalities. Study availability and eligibility vary by location and protocol.

577 public trials 53 recruiting studies

Refine in advanced search Browse all conditions

Congenital Abnormalities trial results

Completed

Oblimersen, Cytarabine, and Daunorubicin in Treating Older Patients With Acute Myeloid Leukemia

NCT00039117

Conditions: Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute Myeloid Leukemia With t(16;16)(p13;q22), +5 more
Locations: Ohio State University Medical Center Columbus, Ohio, United States

View Trial Details

Completed

Irradiated Donor Lymphocyte Infusion in Treating Patients With Relapsed or Refractory Hematologic Cancer or Solid Tumor

NCT00161187

Conditions: Adenocarcinoma, Adnexal Diseases, Blast Crisis, +151 more
Locations: Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School New Brunswick, New Jersey, United States

View Trial Details

Completed

Decision Making About Participating in Pharmacokinetic Studies in Patients Enrolled in a Phase I Treatment Clinical Trial

NCT00890435

Conditions: Astrocytoma, Bone Marrow Diseases, Brain Diseases, +67 more
Locations: Not specified

View Trial Details

Completed

Fludarabine, Cyclophosphamide, and Total-Body Irradiation in Treating Patients Who Are Undergoing a Donor Bone Marrow Transplant for Hematologic Cancer

NCT00134004

Conditions: Blood Coagulation Disorders, Blood Platelet Disorders, Blood Protein Disorders, +63 more
Locations: Blood and Marrow Transplant Program at Northside Hospital Atlanta, Georgia, United States

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States

Hahnemann University Hospital Philadelphia, Pennsylvania, United States

View Trial Details

Completed

Studying Gene Expression in Tissue Samples From Patients With Acute Myeloid Leukemia

NCT01057095

Conditions: Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hematologic Diseases, +6 more
Locations: Not specified

View Trial Details

Completed

S0106 Cytarabine and Daunorubicin w/ or w/o Gemtuzumab Followed By HD Cytarabine and Either Gemtuzumab or Nothing in de Novo AML

NCT00085709

Conditions: Bone Marrow Diseases, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +14 more
Locations: Providence Cancer Center Anchorage, Alaska, United States

Hembree Mercy Cancer Center at St. Edward Mercy Medical Center Fort Smith, Arkansas, United States

Arkansas Cancer Research Center at University of Arkansas for Medical Sciences Little Rock, Arkansas, United States

Alta Bates Summit Comprehensive Cancer Center Berkeley, California, United States

View all 279 locations

View Trial Details

Completed

Bortezomib, Mitoxantrone, Etoposide, and Cytarabine in Relapsed or Refractory Acute Myeloid Leukemia

NCT01127009

Conditions: Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally Differentiated Myeloid Leukemia (M0), Adult Acute Monoblastic Leukemia (M5a), +27 more
Locations: Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center Cleveland, Ohio, United States

View Trial Details

Completed

Alvocidib, Cytarabine, and Mitoxantrone in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia

NCT00407966

Conditions: Adult Acute Basophilic Leukemia, Adult Acute Eosinophilic Leukemia, Adult Acute Megakaryoblastic Leukemia (M7), +31 more
Locations: Johns Hopkins University/Sidney Kimmel Cancer Center Baltimore, Maryland, United States

View Trial Details

Completed

Tipifarnib, Cytarabine, and Daunorubicin in Treating Older Patients With Acute Myeloid Leukemia

NCT00101153

Conditions: Bone Marrow Diseases, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +14 more
Locations: McMaster Children's Hospital at Hamilton Health Sciences Hamilton, Ontario, Canada

London Regional Cancer Program at London Health Sciences Centre London, Ontario, Canada

View Trial Details

Completed

Comparing Three Different Combination Chemotherapy Regimens in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia

NCT00634244

Conditions: Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally Differentiated Myeloid Leukemia (M0), Adult Acute Monoblastic Leukemia (M5a), +26 more
Locations: University of Alabama at Birmingham Birmingham, Alabama, United States

Mayo Clinic in Arizona Scottsdale, Arizona, United States

Mayo Clinic in Florida Jacksonville, Florida, United States

Northwestern University Chicago, Illinois, United States

View all 20 locations

View Trial Details

Congenital Abnormalities

Congenital Abnormalities trial results

Related conditions